ADRA1D antibody (C-Term)
Quick Overview for ADRA1D antibody (C-Term) (ABIN929406)
Target
See all ADRA1D AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Purification
- Purified
-
Immunogen
- ADRA1 D antibody was raised in rabbit using the C terminal of ADRA1 as the immunogen
-
-
-
-
Application Notes
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
ADRA1D Blocking Peptide, catalog no. 33R-1312, is also available for use as a blocking control in assays to test for specificity of this ADRA1D antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- ADRA1D (Adrenergic Receptor, alpha 1d (ADRA1D))
-
Alternative Name
- ADRA1D
-
Background
- Alpha-1-adrenergic receptors (alpha-1-ARs) are members of the G protein-coupled receptor superfamily. They activate mitogenic responses and regulate growth and proliferation of many cells. There are 3 alpha-1-AR subtypes: alpha-1A, -1B and -1D, all of which signal through the Gq/11 family of G-proteins and different subtypes show different patterns of activation. This gene encodes alpha-1D-adrenergic receptor. Similar to alpha-1B-adrenergic receptor gene, this gene comprises 2 exons and a single intron that interrupts the coding region. Synonyms: Polyclonal ADRA1D antibody, Anti-ADRA1D antibody, adrenergic, alpha-1D-, receptor antibody, ADRA1 antibody, ADRA1A antibody, ADRA1R antibody, ALPHA1 antibody, DAR antibody, dJ779E11.2 antibody.
Target
-